Synaptogenix Inc (SNPX)

[Antti]

Well, depends on what clock we are talking about :).

The one I meant is the one that starts counting once/if we get good data from the current trial. IMO it's from that point onwards when BP companies really start they engines regarding Neurotrope and PKC epsilon hypothesis. I think so far the talk has been on general level, just like they talk to many other companies. Like "sounds very promising, if you can prove that, let's talk more".

Of course many of us and the company already see that the data collected so far is already extremely compelling. But that's obviously not yet enough for most, including BP, and what we need is to get a successful primary endpoint. And it's not actually so different from many many other biotechs out there. Sub group data is usually cast aside, no matter how good it looks once you look past the headline. It's usually all about primary endpoint.